The TGA’s Advisory Committee
on the Safety of Medicines has
published the outcome of a
review of combined hormonal
contraceptive products and risks
associated with increased risks of
venous thromboembolism (VTE) &
arterial thromboembolism (ATE).
The TGA had previously noted
that precautions for VTE and ATE in
the Australian Product Information
documents have become “overly
long and confusing for prescribers”
with a lack of consistency.
The committee has supported
“harmonisation and clarity” across
the PI documents for the more than
60 medicines approved for supply
in Australia which contain various
combinations of progestogens
and oestrogens for hormonal
contraception.The above article was sent to subscribers in Pharmacy Daily's issue from 08 Jul 15 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 08 Jul 15
IN WESTERN Australia, Michael’s Chemist Group has started stocking therapeutic Nicotine Vaping Products (NVPs), pursuant to the Federal Government’s new vaping laws (PD 25 Mar).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.